First Time Loading...

Biogaia AB
STO:BIOG B

Watchlist Manager
Biogaia AB Logo
Biogaia AB
STO:BIOG B
Watchlist
Price: 135.5 SEK 2.11% Market Closed
Updated: May 16, 2024
Section:
 

Relative Value

The Relative Value of one BIOG B stock under the Base Case scenario is 92.66 SEK. Compared to the current market price of 135.5 SEK, Biogaia AB is Overvalued by 32%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

BIOG B Relative Value
Base Case
92.66 SEK
Overvaluation 32%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

10.6
P/S
P/S
Price to Sales
10.6
vs History
20
vs Industry
46
Median 3Y
9.2
Median 5Y
8
Industry
8.2
Forward
9.6
More Details
37.5
P/E
P/E
Price to Earnings
37.5
vs History
22
vs Industry
5
Median 3Y
32.1
Median 5Y
24.2
Industry
27.4
Forward
33.8
More Details
32.1
P/OCF
P/OCF
Price to OCF
32.1
vs History
25
vs Industry
6
Median 3Y
30.9
Median 5Y
26.7
Industry
24.3
More Details
37.3
P/FCFE
P/FCFE
Price to FCFE
37.3
vs History
20
vs Industry
5
Median 3Y
34.4
Median 5Y
29
Industry
23
More Details
6.7
P/B
P/B
Price to Book Value
6.7
vs History
0
vs Industry
13
Median 3Y
5.2
Median 5Y
4.7
Industry
2.6
More Details
9.4
EV/S
EV/S
Enterprise Value to Sales
9.4
vs History
17
vs Industry
40
Median 3Y
8
Median 5Y
6.8
Industry
7.5
Forward
8.5
More Details
12.8
EV/GP
EV/GP
Enterprise Value to Gross Profit
12.8
vs History
17
vs Industry
35
Median 3Y
10.9
Median 5Y
9.3
Industry
9.3
More Details
25.9
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
25.9
vs History
19
vs Industry
5
Median 3Y
22.1
Median 5Y
19
Industry
4.3
Forward
23.6
More Details
27.4
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
27.4
vs History
20
vs Industry
5
Median 3Y
23.6
Median 5Y
20.1
Industry
4.2
Forward
24.9
More Details
28.5
EV/OCF
EV/OCF
Enterprise Value to OCF
28.5
vs History
25
vs Industry
6
Median 3Y
26.4
Median 5Y
22.1
Industry
5.9
More Details
32.2
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
32.2
vs History
19
vs Industry
5
Median 3Y
28.2
Median 5Y
24
Industry
3.3
More Details
15.4
EV/IC
EV/IC
Enterprise Value to IC
15.4
vs History
11
vs Industry
17
Median 3Y
12.2
Median 5Y
9.9
Industry
4.9
More Details

Multiples Across Competitors

BIOG B Competitors Multiples
Biogaia AB Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
SE
Biogaia AB
STO:BIOG B
13.7B SEK 10.6 37.5 25.9 27.4
US
Abbvie Inc
NYSE:ABBV
289.1B USD 5.3 60 13 19.8
US
Amgen Inc
NASDAQ:AMGN
171.1B USD 5.8 45.5 19.1 31.4
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
112.7B USD 11.4 31.1 25.2 26.4
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
107.8B USD 8.2 27.9 22.6 25.1
AU
CSL Ltd
ASX:CSL
136.7B AUD 6.4 36.6 22.1 27.4
US
Gilead Sciences Inc
NASDAQ:GILD
83.7B USD 3 172.9 7 9.1
US
Moderna Inc
NASDAQ:MRNA
49.3B USD 9.6 -8.3 -9.1 -8.1
US
Seagen Inc
NASDAQ:SGEN
43.1B USD 18.8 -57.5 -61.9 -55.8
US
Biogen Inc
NASDAQ:BIIB
34.2B USD 3.5 29.3 14.9 18.6
KR
Celltrion Inc
KRX:068270
39.6T KRW 18.2 73.8 45.2 62.2

See Also

Summary
BIOG B intrinsic value, competitors valuation, and company profile.
DCF Valuation
BIOG B stock valuation using Discount Cash Flow valuation method.
Relative Valuation
BIOG B stock valuation using valuation multiples.
Wall Street Estimates
BIOG B price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
BIOG B stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 137,600+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.